CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 39 filers reported holding CITIUS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,880 | -53.6% | 11,514 | -18.6% | 0.00% | – |
Q2 2023 | $16,970 | -65.1% | 14,142 | -77.0% | 0.00% | -100.0% |
Q4 2022 | $48,674 | -13.1% | 61,613 | +32.4% | 0.00% | -50.0% |
Q3 2022 | $56,000 | +166.7% | 46,553 | +126.4% | 0.00% | – |
Q4 2020 | $21,000 | +75.0% | 20,558 | +96.9% | 0.00% | – |
Q2 2020 | $12,000 | – | 10,439 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Inspire Advisors, LLC | 196,867 | $181,000 | 0.05% |
Wealth Advisory Solutions, LLC | 156,850 | $144,000 | 0.04% |
Horst & Graben Wealth Management LLC | 75,722 | $70,000 | 0.02% |
Ergoteles LLC | 451,890 | $416,000 | 0.01% |
Miller Investment Management, LP | 50,000 | $46,000 | 0.01% |
Virtu Financial LLC | 81,410 | $75,000 | 0.01% |
Y-Intercept (Hong Kong) Ltd | 17,342 | $16,000 | 0.00% |
Kestra Advisory Services, LLC | 71,102 | $65,000 | 0.00% |
Csenge Advisory Group | 15,000 | $14,000 | 0.00% |
Qube Research & Technologies Ltd | 121,281 | $112,000 | 0.00% |